Journal
APPLIED SURFACE SCIENCE
Volume 258, Issue 19, Pages 7523-7529Publisher
ELSEVIER
DOI: 10.1016/j.apsusc.2012.04.076
Keywords
SBA-15; APTES; Ketoprofen adsorption; Drug release
Categories
Funding
- European Union
- Ministry of Science and Higher Education - Poland [N N204 028038]
Ask authors/readers for more resources
SBA-15 ordered mesoporous silica functionalized with (3-aminopropyl)triethoxysilane (APTES) was used as the carrier for anti-inflammatory drug: 2-(3-benzoylphenyl)propionic acid - ketoprofen. The surface of SBA-15 containing free silanol groups was modified with 3-aminopropyltriethoxysilane via post-synthetic reaction. Functionalization of the carrier with basic aminopropyl groups resulted in an ionic interaction with acidic ketoprofen. The samples of carriers and carrier-drug complexes were characterized by elemental analysis, TG, N-2 adsorption, FTIR, DRUV spectroscopies and an in vitro drug release test. The adsorption of ketoprofen on modified mesoporous matrix was proportional to the amount of introduced aminopropyl groups. The maximum content of deposited drug in modified SBA-15 was close to 20 wt.%. After drug adsorption the reduction of BET surface area, pore volume and pore diameter of non-modified SBA-15 and aminopropyl-modified SBA-15 after drug adsorption were observed while the hexagonal array of siliceous matrix was well preserved. The release profiles of the aminopropyl-modified drug-containing SBA-15 exhibited prolonged release of ketoprofen in applied media. Tests performed in acidic solution (pH 1.2) showed the best pharmaceutical availability. (C) 2012 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available